Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Robotic Prostatectomy Has Low Complication Rate

By HospiMedica International staff writers
Posted on 14 Sep 2010
A new study presents evidence supporting the safety of the robotic prostatectomy procedure, including what is believed to be one of the lowest complication rates to date.

Researchers at The Cancer Institute of New Jersey (CINJ; New Brunswick, USA) retrospectively examined the medical records associated with the first 200 robotic prostatectomy procedures performed at CNIJ, between January 2006 and December 2007. More...
The patients were divided into four groups according to order of case number. Complications both during and after surgery were determined according to Clavien classification--a common scale used to help identify level of surgical complications.

The results showed that overall, 24 men (12%) experienced various complications, with 5 of the men experiencing complications during surgery and 19 exhibiting postoperative complications. No significant differences were reported between the group with complications and the group without in terms of age, body-mass index (BMI), biopsy Gleason score, and operative time. The study did show however, that those patients who experienced complications did have a higher prostate specific antigen (PSA) level, larger estimated blood loss, and longer hospital stay. The study was published the September 2010 issue of the Journal of Endourology.

"Many studies on negative surgical outcomes related to robotic prostatectomy have been reported, but we believe to date, our study is demonstrating one of the lowest overall complication rates of 12% without any grade four or five complications,” said lead author Isaac Yi Kim, M.D., Ph.D., chief of the CINJ section of urologic oncology, who performed the surgeries. "And as we continue to analyze patient outcomes after every 50 procedures, we are able to better recognize and address adverse trends in order to improve safety, thus helping to provide ideal outcomes for patients.”

The robotic prostatectomy procedure, which has become more commonplace over the past decade, results in a shorter hospital stay, less blood loss, and faster recovery of sexual and urinary functions compared to the traditional surgical method of radical retropubic prostatectomy. In 2008, 60% of radical prostatectomies performed in the United States were completed with the robotic method.

Related Links:
The Cancer Institute of New Jersey



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Adjustable Mobile Barrier
M-458
Endoscopy Display
E190
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.